(Alliance News) - Syncona Ltd on Thursday reported a fall in its net asset value but said it is well-positioned to deliver value as market conditions in biotech improve. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature private companies in its portfolio until it has been able to return up to GBP250 million to shareholders "in a timely manner". The returns, representing about 40% of the company's current market value, could take the form of a tender offer, share buyback, or special dividend, Syncona says. Read More
(Alliance News) - Stock prices in London opened higher on Tuesday as investors digested fresh UK borrowing figures showing the government's finances remain under pressure, even as sentiment improved globally. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Syncona Ltd on Thursday said its net asset value increased during the first quarter of its financial year, citing strong clinical execution. Read More
(Alliance News) - The FTSE 100 was called in the green on Friday, while new UK labour market data has shown "modest growth" in new postings last month. Read More
(Alliance News) - London stocks were mostly lower at midday on Thursday, after the Bank of England left its key rates unchanged at 4.25%. However, three Monetary Policy Committee members voted for a 25 basis point cut. Read More
(Alliance News) - Syncona Ltd shares climbed on Thursday as it proposed a change of investment objective to move to an orderly realisation of assets, as it reported a decline in net asset value. Read More
(Alliance News) - Stock prices in London opened mostly in the red on Thursday, with US markets closed for Juneteenth and all eyes on the Bank of England's interest rate decision. Read More
(Alliance News) - The FTSE 100 was called to open lower on Thursday, ahead of the Bank of England's interest rate decision at midday London time. Read More
Syncona Ltd - London-based investor in healthcare companies - Portfolio company Spur Therapeutics Ltd announces new data from its gene therapy programmes in Gaucher disease, adrenomyeloneuropathy (AMN) and GBA1 Parkinson's disease, presented at the annual meeting of the American Society of Gene & Cell Therapy. Read More
(Alliance News) - Syncona Ltd on Wednesday noted its investee Beacon Therapeutics Holdings Ltd received positive data from its trial of laru-zova for the treatment of patients with X-linked retinitis pigmentosa. Read More
(Alliance News) - Syncona Ltd on Thursday reported a negative net asset value total return for the financial year to date, despite NAV rising during its third quarter. Read More